SECTRAL

This brand name is authorized in France, South Africa, Tunisia, UK.

Active ingredients

The drug SECTRAL contains one active pharmaceutical ingredient (API):

1	Acebutolol UNII B025Y34C54 - ACEBUTOLOL HYDROCHLORIDE
	Acebutolol is a beta adrenoceptor antagonist which is cardioselective, i.e. acts preferentially on beta-1 adrenergic receptors in the heart. Its principal effects are to reduce heart rate especially on exercise and to lower blood pressure in hypertensive subjects.
	Read more about Acebutolol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SECTRAL Capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AB04	Acebutolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	61969626, 64000931, 66931921, 67579483
GB	Medicines & Healthcare Products Regulatory Agency	13890, 13892, 13895
TN	Direction de la Pharmacie et du Médicament	9103491, 9103492
ZA	Health Products Regulatory Authority	G/5.2/167, G/5.2/173, G/6.2/166, L/5.2/0147